
News

News

Latest News!


June 11, 2010	Banyu and Santen Launch COSOPT® Combination Ophthalmic Solution: Glaucoma and Ocular Hypertension Drug
May 11, 2010	Santen Announces Financial Results for the Year ended March 31, 2009
Apr 16, 2010	Santen Announces Approval of DIQUAS for Dry Eye Treatment in Japan
Feb 2, 2010	Santen Announces Financial Result for the Third Quarter ended December 31, 2009
Aug 25, 2009	Eternity Natural IOL, a blue-light blocking version of Eternity intraocular lens receives approval from PMDA for marketing in Japan.
May 12, 2009	Santen Announces Financial Results for the Year ended March 31, 2009
Apr 15, 2009	Santen and Merck & Co., Inc Sign Licensing Agreement for Tafluprost, Treatment for Glaucoma and Ocular Hypertension
Mar 10, 2009	Consumer Information on: Xact® Soft Acrylic UV Light-Absorbing Posterior Chamber Intraocular Lens - P080021 available on FDA CDRH Website
Mar 3, 2009	Santen Pharmaceutical Co., Ltd. (Santen) licenses development, manufacturing and marketing rights of its AVS Xact® hydrophobic acrylic lens material to Bausch & Lomb Inc.(B&L)
Feb 2, 2009	FDA Announces Pre-market Approval of Xact® Foldable Hydrophobic Acrylic Ultraviolet Light-Absorbing Posterior Chamber Intraocular Lens (IOL) - Glistening-Free IOL
Nov 5, 2008	Santen Announces Financial Result for the Second Quarter ended September 30, 2008
Oct 17, 2008	Santen Announces Approval of TAPROS™ for Glaucoma and Ocular Hypertension Treatment in Japan
Oct 3, 2008	Santen to Launch Sante 40i OTC Eye Drop